Nusano News

Nusano Announces Isotope Availability

High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial applications VALENCIA, Calif. – January 10, 2025 –...

Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

Apr 20, 2023

Nusano’s Dr. Howard Lewin will take part in a virtual event hosted by Truist Securities on Friday, April 21, 2023, at 3:30 p.m. Eastern.

Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah

Apr 17, 2023

Nusano’s breakthrough production facility will open Q1 2025 in West Valley City, Utah.

Nusano to Present at Jefferies Inaugural Radiopharma Innovation Summit

Mar 27, 2023

Nusano is a featured panelist and speaker at Jefferies Inaugural Radipharma Innovation Summit in New York City on April 3, 2023

Chris Lowe Named CEO

Jan 8, 2023

VALENCIA, Calif. and WEST VALLEY CITY, Utah, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced Chris Lowe as the company’s Chief Executive Officer. As Nusano progresses toward...

Health-Tech Company Nusano To Open an Office in Utah

Jan 8, 2023

SALT LAKE CITY – July 8, 2021 – The Utah Governor’s Office of Economic Opportunity is pleased to announce that Nusano, Inc. will open an office in Utah, adding up to 92 new high-paying Utah jobs in the next 15 years.  “Nusano will be an awesome addition to...

Nusano Raises $41M in Seed Round

Jan 8, 2023

Nusano (previously known as Alpha Source Inc./Alpha Isotopes) filed paperwork with the United States Securities and Exchange Commission on October 24, 2018 detailing a $41 million seed funding round from investors. With its patented technology, Nusano is working...